Chess Tournament – Tromso Sjakklubb http://tromsosjakklubb.com/ Mon, 01 Aug 2022 05:16:25 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://tromsosjakklubb.com/wp-content/uploads/2021/08/icon-16.png Chess Tournament – Tromso Sjakklubb http://tromsosjakklubb.com/ 32 32 Share Market Live: Sensex rises 200 pts, Nifty above 17,200; M&M and Tata Steel are the top winners https://tromsosjakklubb.com/share-market-live-sensex-rises-200-pts-nifty-above-17200-mm-and-tata-steel-are-the-top-winners/ Mon, 01 Aug 2022 03:23:44 +0000 https://tromsosjakklubb.com/share-market-live-sensex-rises-200-pts-nifty-above-17200-mm-and-tata-steel-are-the-top-winners/ Indian market opened higher today Sensex rose 193 pts to 57,764 and Nifty gained 65 pts to 17,223 in early trade. Benchmarks ended higher for the third consecutive session on Friday, led by strong purchases of metals, consumer durables and IT stocks. Sensex jumped 712 points to finish at 57,570 and Nifty advanced 228 points […]]]>

Indian market opened higher today Sensex rose 193 pts to 57,764 and Nifty gained 65 pts to 17,223 in early trade. Benchmarks ended higher for the third consecutive session on Friday, led by strong purchases of metals, consumer durables and IT stocks. Sensex jumped 712 points to finish at 57,570 and Nifty advanced 228 points to 17,158.

Stocks in the news: YES Bank, NTPC, SpiceJet, Indian Oil, HDFC and more

Here’s a look at today’s live market updates.

10:11 am: IDFC First Bank shares rise 6.5% on record first-quarter profit

Shares of IDFC First Bank gained more than 6% today after the lender reported its highest-ever net profit for the quarter ending June 2022, helped by lower provisioning and revenue higher.

IDFC First Bank shares opened with a gain of 4.93% at Rs 39.40 today. IDFC First Bank’s stock rose 6.52% intraday to Rs 40 against the previous close of Rs 37.55 on BSE. IDFC First Bank shares are trading above the 5-day, 20-day, 50-day and 100-day moving averages, but below the 200-day moving averages.

9:36 a.m.: The rupee rose 13 paise to 79.11 against the US dollar in early trading.

9:18 am: Opening of the market

Sensex climbed 193 pts to 57,764 and Nifty gained 65 pts to 17,223 at the start of the trade.

9:13 a.m.: Expert grip

Prashanth Tapse – Research Analyst, Senior Vice President (Research), Mehta Equities

“Domestic equities are set to get off to a positive start after gains in other Asian indexes after Friday’s firm shutdown in US markets boosted investor sentiment. After the Fed’s rate hike decision last week, all eyes will be riveted on RBI MPC interest rate decision in Aug. 5. Rue expects RBI to hike repo rates another 50bps to 5.4% from 4, 9% currently.The market will also keep an eye on the July auto sales figures which will arrive later in the day, as this would be a likely indication of the health of the macro economy.However, we suspect that the indices Dalal Street benchmarks will show volatility with any excessive upside capped around the 17500-17750 area and will likely break down sharply if Nifty slips below its biggest support at 16901.”

8:34 a.m.: expert grip

Nagaraj Shetti, Technical Research Analyst, HDFC Securities

“The underlying trend of the Nifty is strongly bullish. The unfilled bullish opening gaps, the strong bullish vertical move and the decisive upside break of significant overhead resistance indicate more of a future for the market ahead. Bullish targets to watch are around 17,600-17,800 levels over the next few weeks, but minor downside corrections/consolidations in between cannot be ruled out.Strong support is placed at the 16,950-16,800 levels. »

8:20 am: SGX Nifty

The Indian market is likely to open higher today as SGX Nifty rose 19 points to 17,250. The Singapore Stock Exchange is seen as the first sign of the Indian market opening.

8:15 a.m.: Market on Friday

Benchmarks ended higher for the third consecutive session on Friday, led by strong purchases of metals, consumer durables and IT stocks. Sensex jumped 712 points to finish at 57,570 and Nifty advanced 228 points to 17,158. Tata Steel, Sun Pharma, Bajaj Finserv and IndusInd Bank were Sensex’s biggest gainers, rising 7.27%. Dr Reddy’s, Kotak Bank, SBI, ITC and Axis Bank were Sensex’s only losers, dropping as much as 1.19%.

]]>
Cardiac Safety Services Market Research: Methodology and Rapid Growth in Technology to Drive Industry Revenue: Biotrial, Banook Group, Bioclinica, Certara LP https://tromsosjakklubb.com/cardiac-safety-services-market-research-methodology-and-rapid-growth-in-technology-to-drive-industry-revenue-biotrial-banook-group-bioclinica-certara-lp/ Thu, 28 Jul 2022 13:22:18 +0000 https://tromsosjakklubb.com/cardiac-safety-services-market-research-methodology-and-rapid-growth-in-technology-to-drive-industry-revenue-biotrial-banook-group-bioclinica-certara-lp/ The latest report on the Cardiac Safety Services Market provides a comprehensive overview of key industry issues characteristics, including production, market growth rate, industry share, consumption value and volumedemand for specific types of products and services, and more. The publication focuses on providing a competitive edge to new entrants to the industry and those aiming […]]]>

The latest report on the Cardiac Safety Services Market provides a comprehensive overview of key industry issues characteristics, including production, market growth rate, industry share, consumption value and volumedemand for specific types of products and services, and more. The publication focuses on providing a competitive edge to new entrants to the industry and those aiming to enter the market in the next few years. It offers information on the latest consolidations, acquisitions, associations, buyers and sellers who have had a significant impact on this sector of the industry, as well as experiments with posting serious business scenes in recent years.

The study report offers projections of the industrial market demand prognosis for a given period. Additionally, it provides essential insights into the market complexities and economic environment, along with key insights for readers to capitalize on the various industry patterns.

This article is the latest research on the COVID-19 outbreak review of effects. The impact of the pandemic on demand and the supply chain, as well as the financial situation of the industry, are detailed here. The study also analyzes the gaps in industry dynamics and presents the trends in a post-COVID-19 context, as well as a futuristic perspective.

Get the latest sample PDF report: https://www.worldwidemarketreports.com/sample/817776

Segmentation based on key players

◘ Bioassay
◘ Banook Group
◘ Bioclinical
◘ Certara LP
◘ Celerion
◘ Inc.
◘ ERT
◘ Inc.
◘ Corporation of America Holdings Laboratory
◘ Medpace Holdings
◘ Inc.
◘ Ncardia SA
◘ Richmond Pharmacology
◘ PhysioStim
◘ IQVIA
◘ BioTelemetry
◘ Inc.
◘ Development of pharmaceutical products
◘ LLC
◘ Shanghai Medicilon Inc.
◘ SGS S.A.
◘ Spaulding Clinical Research
◘ LLC

Type-Based Segmentation

◘ by type
◘ Integrated services
◘ Autonomous services
◘ by service type
◘ Cardiovascular Imaging
◘ In-depth QT studies
◘ Blood pressure measurement
◘ ECG measurement
◘ Others

Application-based segmentation

◘ Pharmaceutical and biopharmaceutical companies
◘ Contract Research Organization (CRO)
◘ Others

Get a sample PDF brochure, click here: https://www.worldwidemarketreports.com/sample/817776

Main highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022-2028)
Porter’s Five Forces Analysis
Market drivers and success factors
SWOT analysis
Value chain

Complete mapping of the competitive landscape

This study is a compilation of primary and secondary research which represent market size, share, trends and forecasts for major segments and sub-segments taking into account macro and micro environmental aspects. It also assesses the bargaining power of suppliers and buyers, the threat of new entrants and product substitutes, and the level of competition in the market.

Competition Quadrants

The report contains a Competitive Quadrant, a proprietary tool for analyzing and evaluating a company’s position based on its industry position scores and market performance. The tool divides players into four groups based on a number of characteristics. Financial performance over the previous three years, growth strategies, innovation score, new product launches, investments, market share growth, etc. are some of the elements evaluated for analysis.

FAQs

The document examines all major players in the Cardiac Safety Services industry and provides solutions to some of the most pressing questions:

• Who is currently the market leader?

• What is the market share of the top player?

• What are the major players’ revenue in the Cardiac Safety Services segment?

• What are the chances of a new company entering this market?

• What products/services do these companies offer?

Buy this research report: https://www.worldwidemarketreports.com/buy/817776

The following items are included in the report:

  • Key Development Drivers, Limitations, Opportunities and Issues of the Market.
  • Global and regional developments are scrutinized.

The report answers the following key questions:

  • What will be the market size and growth rate by the end of the forecast period?
  • What are the key Cardiac Safety Services market trends influencing market growth?
  • What are the growth prospects and threats of the major competitors in the market?
  • What are the key findings of Porter’s Five Forces analysis and SWOT analysis of the leading companies in the Global Cardiac Safety Services Market?
  • What opportunities and dangers are the manufacturers facing in the Global Cardiac Safety Services Market?

Contact us :

Mr Shah
Global Market Reports,
Tel: USA +1-415-871-0703
UK +44-203-289-4040
Japan +81-50-5539-1737
E-mail: [email protected]
Website: https://www.worldwidemarketreports.com/

]]>
WineInk: Gamble Family Vineyards Supports Napa’s Future https://tromsosjakklubb.com/wineink-gamble-family-vineyards-supports-napas-future/ Sun, 24 Jul 2022 20:16:00 +0000 https://tromsosjakklubb.com/wineink-gamble-family-vineyards-supports-napas-future/ The sun sets over Napa Valley and the “Family Home” vineyard of the Gamble Family Winery in the Oakville AVA.Sarah Anne Risk, courtesy of Gamble Vineyards It’s easy to forget that behind every bottle of wine there is a farmer. As consumers (and wine writers) we can get so wrapped up in tasting notes, pedigree, […]]]>
The sun sets over Napa Valley and the “Family Home” vineyard of the Gamble Family Winery in the Oakville AVA.
Sarah Anne Risk, courtesy of Gamble Vineyards

It’s easy to forget that behind every bottle of wine there is a farmer. As consumers (and wine writers) we can get so wrapped up in tasting notes, pedigree, packaging and all the glamor and shine that surrounds a bottle of wine that we often overlook the fact that it it is an agricultural product, born in the earth, produced from plants and made by farmers.

But a recent conversation with Tom Gamble, a third-generation Napa farmer who produces some of the region’s best wines under the Gamble Family Vineyards label, put that into perspective.

“Our ability to make great wines depends on the terroir and the environment,” he said of the 175 acres of vineyard land he owns in five of Napa’s most prestigious appellations. “All of the natural conditions that affect growing conditions are what make great wines. These are special places.



Special indeed. In recent months, there has been an explosion of vineyard and land consolidation in Napa Valley. Long-standing, family-run wineries like Shafer Vineyards, Joseph Phelps Vineyards and Frank Family Vineyards – to name a few – have been taken over by big corporations in massive takeovers, with prices in the hundreds. millions of dollars. There is a rush for land and a thirst for vineyards that has driven prices to new levels.

But for Gamble, whose grandfather began acquiring property in Napa County in 1916, the plan is not to turn over the vines, but rather to continue building something for the long term, where quality and the integrity of wines matter.



“Our challenge is to successfully navigate generational change and the evolution of what we have here. It comes both from living with the land and from my family history,” he said.

Gamble’s hope is that the future will include several of his dozens of nieces and nephews, as well as those of his wife, who will be part of the next generation.

“All have a love of the land, and all could be good landlords,” he said.

Farming and Family: Sounds romantic, but it’s harder than it looks. In addition to recent consolidations within the Valley and shifts in industry tastes, there have been fires and pandemics to navigate. But for Gamble, the game remains the same.

“I have a winery addiction,” he laughed of his holdings in AVAs in Oakville (Family Home), Rutherford (CC Ranch), Yountville, Mt. Veeder and Coombsville. “Maybe I need a 12-step program.”

Gamble Family Vineyards launched its first vintage in 2005. For the past fifteen years it has produced excellent bottlings of Cabernet Sauvignon from the best fruit from its own vineyards, although the company sells the majority of its grapes to other wine producers.

“Our wines are not designed to have the loudest voice. Rather, we strive to produce nuanced wines, not blockbusters. We try to keep the alcohol below 14% and make wines that go well with food,” said Gamble, when asked to define the distinctive style produced by Gamble Family.

Premium Cabernet Sauvignon wines and Bordeaux blended wines under the Gamble Family label are made in limited quantities and have, to date, been sold under the Napa appellation. About half of the wines are sold directly to consumers, either at the Oakville winery or to wine club members, with the other half offered at the wholesale market. Gamble said he just struck a deal with a distributor in Colorado, so we can expect to see those wines here soon.

He’s also excited about a relatively new project called The Mill Keeper, a less expensive selection of Napa wines, which take advantage of fruit that isn’t used for high-end bottling.

“Don’t waste, don’t want,” he said of the source of the fruit used in Mill Keeper. “We drop great fruit from the vines every harvest that can still make great wines that we can sell at a bargain price.”

In addition to using fruit that would otherwise be wasted, Mill Keeper wines are MV or multi-vintage wines. This means that the wines are sourced from different harvest years, much like champagne and non-vintage ports, then blended to take advantage of the unique strengths of the different harvests.

This summer has brought significant changes to Gamble family wines as they continue to evolve to meet the challenges of being independent in an increasingly competitive corporate environment. In June, longtime winemaker Jim Close, who has produced every bottle of Gamble family wine to date and has been with the company for nearly 20 years, decided to write another chapter.

“Jim felt like trying something new,” Gamble said. “Although sorry to see him go, we were really lucky to have him here for 19 years. But he agreed to help us with our transition.

Gamble began this transition by contracting with Atelier Melka, the superstar wine consulting team led by Bordeaux-trained Napa legend Philippe Melka. Melka, who has been part of some of Napa’s most beloved wine projects over the past three decades, gets to choose his customers and is a credit to the winery he has become involved with.

“I’ve known Phillipe for a number of years, and he topped a very short list,” Gamble said.

Melka brings his team with him, including Israeli-born winemaker Maayan Koschitzky, who moved to Napa in 2011 and whose resume includes stints at both Screaming Eagle and Dalla Valle.

“Change is evolutionary. This is going to bring stability, giving us a long-term solution that keeps us on a trajectory,” Gamble said.

The plan is to start releasing wines that are designated sub-AVA and extract the gold that is dirt in the vineyards.

“As we have replanted and continue to replant our wine properties, we do so in the spirit of improving quality and sustainability,” Gamble emphasized. “Coupled with these intense viticultural efforts, I am certain that the expertise of the Melka team will continue to lift the wines of Gamble Family Vineyards for years to come.

As anyone who has visited the former white barn and winery at The Gamble Family Ranch knows, sustainability is a benchmark of the property. Gamble is involved in the Napa Green Winery and Vineyard sustainability projects, and his mother was involved in the groundbreaking 1968 classification, which designated that “agriculture is, and should continue to be, the predominant use of land and excludes the development of urban uses detrimental to the maintenance of agriculture. »

“It comes from living with the land,” Gamble said. “My mother was a soldier in the struggle to pass the Napa Valley Agricultural Reservation.”

The fight changed the course of history in Napa Valley and obviously resonates with Gamble to this day.

Oh, and another change is about to happen. Gamble Family bought one of the first fully electric self-driving tractors. Monarch Tractor of Livermore, California is the Tesla of farm equipment.

“When you think about it, a tractor is perhaps the most important vehicle in the world. This is what allows food systems to thrive,” he said.

The tractor is a product of modern technology combined with farming tradition – just like Tom Gamble himself.

Cabernet from the Keeper of the Mill. Courtesy of Gamble Vineyards.
Courtesy of Gamble Vineyards.
A farmer checks his crops. Tom Gamble takes a spring walk through his vines on Mount Veeder at bud break. Sarah Anne Risk courtesy of Gamble Vineyards.
Sarah Anne Risk, courtesy of Gamble Vineyards.
The old barn in Oakville is the signature of visitors who come to taste the wines of the Gamble family. Sarah Anne Risk courtesy of Gamble Vineyards.
Sarah Anne Risk, courtesy of Gamble Vineyards.
Signs at the entrance confirm that Gamble Family vineyards and wines are certified Napa Green. Sarah Anne Risk, courtesy of Gamble Vineyards.
Sarah Anne Risk, courtesy of Gamble Vineyards.

]]>
Global Robotic Surgical Systems Market to 2030 – Players include Globus Medical, Intuitive Surgical, Johnson & Johnson and Medrobotics – ResearchAndMarkets.com https://tromsosjakklubb.com/global-robotic-surgical-systems-market-to-2030-players-include-globus-medical-intuitive-surgical-johnson-johnson-and-medrobotics-researchandmarkets-com/ Fri, 22 Jul 2022 13:23:00 +0000 https://tromsosjakklubb.com/global-robotic-surgical-systems-market-to-2030-players-include-globus-medical-intuitive-surgical-johnson-johnson-and-medrobotics-researchandmarkets-com/ DUBLIN–(BUSINESS WIRE)–The “Robotic Surgical Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend & SWOT Analysis, Regulatory & Reimbursement Landscape, Procedures & Forecast, 2015-2030” report has been added to from ResearchAndMarkets.com offer. This report is designed to visualize quantitative market trends in the therapeutic area of ​​General Surgical Devices. The model examines in detail […]]]>

DUBLIN–(BUSINESS WIRE)–The “Robotic Surgical Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend & SWOT Analysis, Regulatory & Reimbursement Landscape, Procedures & Forecast, 2015-2030” report has been added to from ResearchAndMarkets.com offer.

This report is designed to visualize quantitative market trends in the therapeutic area of ​​General Surgical Devices.

The model examines in detail the impact of COVID-19 on the Robotic Surgical Systems market for the year 2020 and beyond. Robotic surgical systems are designed to minimize the limitations of minimally invasive surgery (MIS), as well as improve the outcomes of open surgical procedures. These systems are used for cardiovascular, general surgery, orthopedics, neurosurgery, obstetrics, gynecology and urology procedures.

The major driver of the market is the increasing number of surgical procedures, propelled by the growing aging global population. According to the United Nations, the population of people aged 65 and over will be around 1.5 billion by 2050, which is derived from an annual growth rate of 3% (UNDESA, 2019). Aging populations are at higher risk of developing a multitude of diseases and conditions requiring surgical interventions. This trend will lead to higher volumes of open and minimally invasive procedures, generating an increased need for robotic surgical systems.

Each of the color-coded, fully-sourced market models from the 39 countries covered is equipped with epidemiology-based indications with procedure volumes. To increase data transparency, interactive Excel deliverable covers installed base, new sales volumes, product usage, average sales prices, market size and company share/rank analysis (if applicable). Additionally, analyst commentary with qualitative insight provides context for quantitative data.

The main inclusions of the market model are:

  • Currently marketed robotic surgical systems and the changing competitive landscape.

  • Insightful review of key industry trends.

  • Total annualized revenue of robotic surgical systems market by segment and market outlook from 2015 to 2030.

  • Granular data on total number of procedures, units, average selling prices and market values ​​by segment.

Global, regional and country specific market information:

  • Market-specific qualitative information is available with global trends broken down into regional trends. Additionally, analysts provide unique market insights specific to each country.

  • SWOT analysis for Robotic Surgical Systems Market.

  • Competitive dynamics insights and trends provided for the Robotic Surgical Systems Market.

Improve understanding of the market by getting a true overview, including insight into the healthcare system.

Additionally, the Market Access segment allows you to dig deeper into market dynamics with insights into reimbursement policies and the regulatory landscape.

  • Overview of the health system by country.

  • Country specific refund policies.

  • Country-specific medical technology regulatory landscape.

Robust methodologies and sources allow the model to provide a complete and accurate overview of the market. Both demand and supply side primary sources are integrated into the syndicated models, including key opinion leaders. Additionally, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Intuitive Surgical Inc, Johnson & Johnson, Medrobotics Corp, Medtronic Plc, Smith & Nephew Plc, Stryker Corp, Zimmer Biomet Holdings Inc, Globus Medical Inc, Siemens Healthineers AG, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa South, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Reasons to buy

The model will allow you to:

  • Understand the impact of COVID-19 on the Robotic Surgical Systems Market.

  • Develop and design your licensing and out-licensing strategies through a review of pipeline products and technologies, and identifying the companies with the strongest pipeline.

  • Develop business strategies by understanding the trends shaping and driving the Robotic Surgical Systems market.

  • Generate revenue by understanding the key trends, innovative products and technologies, market segments, and companies that are likely to impact the Robotic Surgical Systems Market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the company’s share among market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.

  • Track device sales in the global and country-specific robotic surgical systems market from 2015 to 2030.

  • Organize your sales and marketing efforts by identifying the categories and market segments that present the maximum opportunities for consolidations, investments and strategic partnerships.

Companies cited

  • Globus Medical Inc

  • Intuitive Surgery Inc

  • Johnson & Johnson

  • Medrobotics Corp.

  • Medtronic AG

  • Siemens Healthineers AG

  • Smith & Nephew Plc

  • Stryker Corporation

  • Zimmer Biomet Holdings Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/v9zif5

Source: Global Data

]]>
Global Articulated Robotic Systems Market Analysis and Trends to 2022-2028 – This Is Ardee https://tromsosjakklubb.com/global-articulated-robotic-systems-market-analysis-and-trends-to-2022-2028-this-is-ardee/ Thu, 21 Jul 2022 03:01:31 +0000 https://tromsosjakklubb.com/global-articulated-robotic-systems-market-analysis-and-trends-to-2022-2028-this-is-ardee/ MarketsandResearch.biz has just published a new market study named Global Articulated Robotic Systems Market. The market study provides a comprehensive overview of the current and future phases of the market on the basis of criteria such as research innovations, complete industrial subdivision, and regional distribution. The report covers the market landscape and its growth prospects […]]]>

MarketsandResearch.biz has just published a new market study named Global Articulated Robotic Systems Market. The market study provides a comprehensive overview of the current and future phases of the market on the basis of criteria such as research innovations, complete industrial subdivision, and regional distribution. The report covers the market landscape and its growth prospects in the coming years. It gives a basic introduction of major vendors, major regions, and product types.

Competitive analysis of major players in the Global Robotic Systems Market includes company profile, product information, price analysis, manufacturing process, raw material cost, raw material suppliers in upstream and downstream buyers, product cost and gross margin analysis.

DOWNLOAD A FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/302652

Market players included in the reports are:

  • FANUC
  • KUKKA
  • ABB
  • Yaskawa
  • kawasaki
  • DENSO
  • Nachi Fujikoshi
  • Epson
  • Staubli
  • OTC
  • COMAU
  • Omron Adept Technologies
  • SIASUN
  • HIWIN (TW)
  • Yamaha
  • GSK
  • Triowin
  • Nanjing Estun Automation

Here, the report also aims to study the market trends in various regions and countries. The research examines new opportunities for growth, carried out with an in-depth analysis of the global Articulated Robotic Systems market based on the development and data analysis considering every aspect of the market. The report fragments the market based on market players, product types, applications, and regions.

By Type, the market is segmented into:

  • 4 axes or less
  • 5 axis
  • 6 axes or more

By Application, market is segmented into:

  • Automotive
  • Electrical and Electronic
  • Machinery
  • Rubber, plastics and chemicals
  • food and drinks
  • Others

Following are the major regions considered for the analysis of the Global Articulated Robotic Systems Market:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

ACCESS THE FULL REPORT: https://www.marketsandresearch.biz/report/302652/global-articulated-robotic-systems-market-2022-by-manufacturers-regions-type-and-application-forecast-to-2028

The report also illustrates the major restraining factors that are negatively impacting the growth of the Global Articulated Robotic Systems Market over the analysis period from 2022 to 2028. This study provides strategic solutions and recommendations in areas of activity based on market estimates. The report sheds light on various dynamic details on regional fronts and country-level developments.

In addition, manufacturers considering a place in the retail sectors in the Global Articulated Robotic Systems Market would find the research material contained in this report highly advantageous. The report also offers an in-depth look at new consolidations, funders, acquisitions, and partners that will strongly affect this rapidly evolving business space over the next few years.

Report customization:

This report can be customized to meet customer requirements. Please contact our sales team (sales@marketsandresearch.biz), who will ensure that you get a report tailored to your needs. You can also get in touch with our executives at +1-201-465-4211 to share your research needs.

Contact us
mark the stone
Business Development Manager
Call: +1-201-465-4211
E-mail: sales@marketsandresearch.biz
The Web: www.marketsandresearch.biz

]]>
South Korean electric scooter company Gbike acquires Hyundai Motor’s ZET micromobility platform – TechCrunch https://tromsosjakklubb.com/south-korean-electric-scooter-company-gbike-acquires-hyundai-motors-zet-micromobility-platform-techcrunch/ Mon, 18 Jul 2022 23:05:24 +0000 https://tromsosjakklubb.com/south-korean-electric-scooter-company-gbike-acquires-hyundai-motors-zet-micromobility-platform-techcrunch/ BikeSouth Korea-based micromobility operator Gcooter acquires shared micromobility platform from Hyundai Motor ZET because it wants to increase its market share and create technological synergies through ZET’s fleet management system. Gbike CEO Walter Yoon told TechCrunch that the deal, which is its first acquisition, will close in early August. Financial terms of the transaction were […]]]>

BikeSouth Korea-based micromobility operator Gcooter acquires shared micromobility platform from Hyundai Motor ZET because it wants to increase its market share and create technological synergies through ZET’s fleet management system.

Gbike CEO Walter Yoon told TechCrunch that the deal, which is its first acquisition, will close in early August. Financial terms of the transaction were not disclosed.

South Korea’s consolidations appear to be starting in the shared micromobility industry after many electric scooter players entered the sector in 2019, Yoon said in an interview with TechCrunch. Gbike was approached by potential buyers for acquisition as the startup was looking for acquisition targets itself, Yoon said, adding that it was in talks with another company to acquire.

“This year could be the time for consolidation [in the e-scooter industry]“, Yoon said. “We are very open to any other opportunity.”

The ZET team will not join the Gbike team and will stay with Hyundai, Yoon noted. The acquisition brings the startup’s total vehicle size to around 45,000. (Gbike, which added a fleet of 20,000 e-scooters last year, will acquire ZET’s fleet of less than 1,000 e-scooters .)

In 2019, Hyundai launched the ZET platform that allows anyone to start a micromobility business in their city. ZET operates its service in major cities in South Korea, including Jeju, Daegu, and Incheon. Yoon explained that ZET is like a micromobility franchise platform, which makes it easier for franchisees to launch their own business.

Yoon pointed out that many e-scooter companies have been suspended or shut down in the past year due to South Korea’s revised regulations, which came into effect in May 2021, requiring e-scooter users to wear helmets, have a valid driver’s license and be 16 years of age or older. .

More than 20 electric scooter rental startups operate more than 50,000 electric scooters in Seoul, the capital of South Korea. Several electric scooter companies, such as Lime, Wind Mobility, Neuron and local companies have closed their operations in South Korea in recent months. Regulatory gaps in the country, such as the lack of a Request for Proposals (RFP) system, which selects a few exceptional operators in each city to provide the best possible micromobility services, have caused user compliance issues such as the parking and congestion.

Gbike has raised a total of $10 million from investors including Mirae Asset Venture Investment, Strong Ventures and SBI Investment.

]]>
The Carlyle Group Inc. (NASDAQ:CG) Receives Consensus “Moderate Buy” Recommendation from Analysts https://tromsosjakklubb.com/the-carlyle-group-inc-nasdaqcg-receives-consensus-moderate-buy-recommendation-from-analysts/ Sun, 17 Jul 2022 07:40:20 +0000 https://tromsosjakklubb.com/the-carlyle-group-inc-nasdaqcg-receives-consensus-moderate-buy-recommendation-from-analysts/ Shares of The Carlyle Group Inc. (NASDAQ: CG – Get a rating) earned an average recommendation of “Hold” from the twelve rating agencies that currently cover the stock, reports Marketbeat.com. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned the company a buy […]]]>

Shares of The Carlyle Group Inc. (NASDAQ: CG – Get a rating) earned an average recommendation of “Hold” from the twelve rating agencies that currently cover the stock, reports Marketbeat.com. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned the company a buy rating. The 12-month average target price among brokerages that have covered the stock over the past year is $58.11.

A number of research analysts have commented on the headline. JMP Securities assumed coverage for The Carlyle Group shares in a Wednesday, June 8 research note. They set an “outperform” rating and a price target of $60.00 for the company. BMO Capital Markets cut its price target on shares of The Carlyle Group from $69.00 to $60.00 in a Friday, April 29 research note. Goldman Sachs Group cut its price target on shares of The Carlyle Group from $58.00 to $48.00 and set a “buy” rating for the company in a Wednesday, June 29 research note. Deutsche Bank Aktiengesellschaft cut its price target on shares of The Carlyle Group from $64.00 to $56.00 and set a “buy” rating for the company in a research note on Wednesday. Finally, Oppenheimer raised his price target on Carlyle Group shares from $71.00 to $80.00 in a Wednesday, April 13 report.

The Carlyle Group is sourcing 4.9%

A d Tradewins

The safest option in the trades!

If you’re new to trading, you’ve probably heard the wrong word about options, that they’re risky, unpredictable, or difficult. And it couldn’t be more wrong! With the Hughes Optioneering strategy, you will soon learn that the safest option for new accounts is the options themselves!

The NASDAQ CG opened at $32.02 on Friday. The company has a debt ratio of 1.25, a quick ratio of 2.65 and a current ratio of 2.65. The company has a 50-day simple moving average of $34.99 and a 200-day simple moving average of $42.39. The Carlyle Group has a 12-month low of $30.01 and a 12-month high of $60.62. The stock has a market capitalization of $11.58 billion, a PE ratio of 4.36, a PEG ratio of 0.32 and a beta of 1.59.

The Carlyle Group (NASDAQ:CG – Get a rating) last released its results on Thursday, April 28. The financial services provider reported earnings per share of $0.74 for the quarter, missing the consensus estimate of $0.98 per ($0.24). The company posted revenue of $779.50 million in the quarter, versus a consensus estimate of $1.06 billion. The Carlyle Group had a net margin of 33.77% and a return on equity of 41.54%. The company’s quarterly revenue increased 27.3% year over year. In the same quarter a year earlier, the company posted EPS of $0.58. On average, research analysts expect The Carlyle Group to post EPS of 3.98 for the current year.

The Carlyle Group increases its dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 17. Investors of record on Tuesday, May 10 received a dividend of $0.325. The ex-dividend date was Monday, May 9. This represents a dividend of $1.30 on an annualized basis and a dividend yield of 4.06%. This is a positive change from The Carlyle Group’s previous quarterly dividend of $0.25. The Carlyle Group’s dividend payout ratio (DPR) is currently 17.69%.

Insider Activity at The Carlyle Group

In related news, the director David M. Rubenstein sold 2,000,000 shares of the company in a transaction that took place on Monday, June 6. The shares were sold at an average price of $38.67, for a total value of $77,340,000.00. Following the completion of the sale, the director now owns 29,249,644 shares of the company, valued at $1,131,083,733.48. The sale was disclosed in a document filed with the SEC, accessible via the SEC website. 29.80% of the shares are currently held by insiders of the company.

Carlyle Group Institutional Negotiation

Institutional investors have recently bought and sold shares of the company. Westside Investment Management Inc. increased its position in shares of The Carlyle Group by 117.6% during the second quarter. Westside Investment Management Inc. now owns 1,284 shares of the financial services provider worth $40,000 after buying an additional 694 shares in the last quarter. IFM Investors Pty Ltd increased its position in shares of The Carlyle Group by 50.9% during the second quarter. IFM Investors Pty Ltd now owns 33,565 shares of the financial services provider worth $1,063,000 after buying an additional 11,325 shares last quarter. Gofen & Glossberg LLC IL increased its position in shares of The Carlyle Group by 15.2% during the second quarter. Gofen & Glossberg LLC IL now owns 30,250 shares of the financial services provider worth $958,000 after buying an additional 4,000 shares last quarter. Zhang Financial LLC increased its position in shares of The Carlyle Group by 6.1% during the second quarter. Zhang Financial LLC now owns 16,787 shares of the financial services provider worth $531,000 after buying 971 additional shares in the last quarter. Finally, LGT Capital Partners LTD. increased its position in shares of The Carlyle Group by 4.7% during the second quarter. LGT Capital Partners LTD. now owns 1,060,000 shares of the financial services provider worth $33,560,000 after purchasing an additional 47,788 shares in the last quarter. Institutional investors and hedge funds hold 93.84% of the company’s shares.

About The Carlyle Group

(Get a rating)

The Carlyle Group Inc is an investment company specializing in direct investments and funds of funds. Within direct investments, she specializes in management led/leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and medium-sized enterprises market, private equity placements, consolidations and accumulations, senior debt, mezzanine and leveraged financing and venture capital and growth capital financings, seed/start-up, business start-up , emerging growth, turnaround, middle business, late business, PIPES.

Featured Articles

Analyst Recommendations for The Carlyle Group (NASDAQ:CG)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in The Carlyle Group right now?

Before you consider The Carlyle Group, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market ripples…and the Carlyle Group didn’t make the list.

While The Carlyle Group currently has a “moderate buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

]]>
Megadeals push healthcare merger activity to $19.2 billion in second quarter https://tromsosjakklubb.com/megadeals-push-healthcare-merger-activity-to-19-2-billion-in-second-quarter/ Fri, 15 Jul 2022 19:49:13 +0000 https://tromsosjakklubb.com/megadeals-push-healthcare-merger-activity-to-19-2-billion-in-second-quarter/ Photo: Mikolette/Getty Images Healthcare mergers and acquisitions had a record quarter in the second quarter of this year, with a record $19.2 billion in total revenue transacted, driven by a few “mega-deals” that led to a doubling revenues traded posted in the first quarter. According Kaufman Hall M&A Quarterly Reportthe planned merger between Advocate Aurora […]]]>

Photo: Mikolette/Getty Images

Healthcare mergers and acquisitions had a record quarter in the second quarter of this year, with a record $19.2 billion in total revenue transacted, driven by a few “mega-deals” that led to a doubling revenues traded posted in the first quarter.

According Kaufman Hall M&A Quarterly Reportthe planned merger between Advocate Aurora Health and Atrium Health — in which the smaller party, Atrium, has annual revenue of $12.9 billion — was the biggest contributor to the historically strong quarter.

In mega deals, or mega deals, the smallest party has annual revenues over $1 billion.

Another mega-deal was announced in the quarter – MercyOne and Trinity Health, the smallest party posting $3 billion in annual revenue. And while they weren’t “mega,” two other big deals took place in the second quarter: Bellin Health System/Gundersen Health System ($800 million in revenue for smaller parties) and George Washington University Hospital/Universal Health Services ($600 million revenue for small parties) .

A total of 13 transactions were announced in the second quarter. That’s small compared to some of the numbers seen before 2020 when the pandemic hit, but mega-deals have more than made up for any potential lag in total deal revenue.

WHAT IS THE IMPACT

The $19.2 billion mark is double what healthcare posted in the second quarter of 2021, when $8.5 billion in revenue was generated. And the size of transactions announced in the second quarter – particularly the planned merger of Advocate Aurora Health and Atrium Health – generated a smaller average party size that was more than double the record year-end average size. of 2021 of $619 million. For the second quarter of 2022, the average small party size approached $1.5 billion.

In three of the 13 transactions, the acquirer was a for-profit health system. In one transaction, there was a university/affiliate acquirer in one university, and there was a religious affiliate acquirer in another. Other nonprofit health systems were the acquirer in the remaining eight transactions.

Some of the agreements went beyond the traditional horizontal partnerships between hospitals and health systems. New partnerships around the provision of skilled nursing and long-term care are an example of this trend: in late March, Hackensack Meridian Health announced that the majority of its long-term care facilities would be acquired by Complete Care. And in April, Virtua Health announced the sale of its two SNFs to Tryko Partners, which will continue to operate the facilities with support from Marquis Health Consulting Services.

These illustrate a growing trend among health systems to reassess strategic options for delivering skilled post-acute care, which may include selling or monetizing their current SNF assets, or partnering with specialist SNF operators. .

Changes in the long-term care sector and the desire to reinvest in basic services were cited as drivers of these transactions. Hackensack Meridian Health’s press release announcing the deal said “The long-term care industry has seen major changes over the past several years as a result of the COVID-19 pandemic, and this decision was taken in accordance with industry trends and best practices”.

Virtua Health President and CEO Dennis W. Pullin said, “By divesting from the skilled nursing field, we are better equipped to reinvest in areas where we can really make an impact.”

THE GREAT TREND

With no mega deals in the first quarter of the year, total deal revenue in that quarter was just $2.9 billion, spread across an all-time low of 12 deals.

An executive order issued by President Joe Biden last summer sought to clamp down on hospital and health insurance consolidations and other actions that he says lessen competition and drive up prices.

Hospital consolidation has left many areas, especially rural communities, without good options for convenient and affordable health services, according to the order. He encouraged the Justice Department and the Federal Trade Commission to vigorously enforce antitrust laws and “recognizes that the law allows them to challenge prior bad mergers that previous administrations did not previously challenge.”

In the order, Biden encouraged the DOJ and FTC to review and revise their merger guidelines to ensure that patients are not harmed by such mergers.

Twitter: @JELagasse
Email the author: jeff.lagasse@himssmedia.com

]]>
Infrastructure as code explained – what container architecture can do for you https://tromsosjakklubb.com/infrastructure-as-code-explained-what-container-architecture-can-do-for-you/ Wed, 13 Jul 2022 13:17:42 +0000 https://tromsosjakklubb.com/infrastructure-as-code-explained-what-container-architecture-can-do-for-you/ Infrastructure-as-Code describes a radical way to accelerate and improve the repeatability of setting up and tearing down infrastructure for development and operations. But it is often only truly understood by those who use it on a daily basis. Let’s change that. What is Infrastructure as Code? Traditionally, infrastructure has been managed and provisioned through manual […]]]>

Infrastructure-as-Code describes a radical way to accelerate and improve the repeatability of setting up and tearing down infrastructure for development and operations. But it is often only truly understood by those who use it on a daily basis.

Let’s change that.

What is Infrastructure as Code?

Traditionally, infrastructure has been managed and provisioned through manual processes. Framework as code is a simpler, text-based way to do this. You create configuration files that contain the infrastructure details you need. This simplifies and standardizes your infrastructure, because by codifying it, it gives you the ability to provision the same environment the same way, every time. This means that you only use proven infrastructure.

What are the benefits of infrastructure as code?

Infrastructure as code helps reduce deployment problems in several ways.

Configuration Management
In addition to repeatability, DevOps can maintain version control, tracking ad-hoc developer changes on the fly. Without this, there is a danger that later stages (QA, production) will fail due to undocumented infrastructure changes.

Cost reduction
Automated infrastructure as code (and there are several handy tools that allow you to achieve automation) can significantly reduce your infrastructure maintenance costs because you don’t waste developers’ time redeploying infrastructure and to manually root out issues, tweak config files individually, and otherwise baby-sit the “Ops” in DevOps.

Faster, more consistent deployments
As the amount of infrastructure that needs to be implemented in cloud computing continues to grow, the faster you can deploy, the better you serve your customers, while saving your business time and money.

The probability of errors in your infrastructure is reduced and you avoid configuration drifts (which, if left unchecked, can quickly lead to chaos). This means that automating your infrastructure as code brings you benefits in terms of cost, consistency, speed and certainty, especially compared to manual infrastructure upgrades.

Infrastructure as code and DevOps
The importance of infrastructure as code to DevOps practices is that it frees your developer community from the provisioning work that would otherwise clog your continuous integration/continuous development cycle. Infrastructure as code means they can just write a text file to get their infrastructure ready to go and keep the development cycle running at the speed you need to stay competitive.

Approaches to infrastructure as code

There are two main ways to automate your infrastructure as code. You can either opt for a declarative approach or an imperative approach.

The declarative approach, as the name suggests, defines system requirements, components, resources you will need, and maintains a list of system objects. This is a bonus when it comes to dismantling infrastructure, as you can check your infrastructure items against the list of system objects, so you can do a thorough job the first time.

The imperative approach is more technical. It defines the specific commands you need to achieve the configuration you want. If you run these commands in the correct order, it can be a faster approach to automation.

Infrastructure as code automation tools

There are many Infrastructure as Code automation tools on the market. Some of the most popular include:

Ansible
Ansible is an extremely popular automation engine, and it can automate a wide range of server setup and configuration tasks. But one thing that explains its popularity among developers is that it’s relatively easy to use and was designed from day one to deal with multi-tier deployments.

There is nothing between the developer and Ansible – no additional layers of security architecture. It also uses a very simple textual language to facilitate rapid deployments (in INI or YAML format). Playbooks are YAML/INI files for the Ansible application.

When an Ansible playbook is run, it connects to your nodes detailed in Ansible’s inventory descriptions, according to the “instructions” in the playbook. These are designed as lists of resources needed to achieve the desired state of the system.

Ansible runs on each node and ranks after itself. For convenience, you can create a library of playbooks for each type of deployment, and playbooks can install on any machine, including where Ansible itself is hosted. Because we are dealing with text files, the space required to describe (and deploy) huge deployments will be relatively small.

Ansible can be extended with an “authorized key” module, which allows you to control which machine hosts Ansible has automated access to. This combination of simplicity, flexibility, security, and speed is what has made Ansible so popular as an automator of Infrastructure as Code.

Puppet

Puppet is a declarative automaton that has become popular by providing consistency in automating very large and complex constructs. It works very simply – it declares the state it needs of the system (which users will exist, what software needs to be installed, what security patches need to be applied) and lets you easily validate that state. Once this has been achieved, you can quickly identify the failures in your model, what went wrong and why, and Puppet can be easily reconfigured with little programming knowledge.

Puppet’s troubleshooting capabilities have propelled it to the forefront of automation tools available for Infrastructure as Code. It offers reliability, consistency, and relative security to modify your infrastructure as you need it, and is available in both open-source and proprietary, enterprise-focused variants.

Chief

Formerly known simply as “Chef”, Progress Chef helps companies build demanding server setups either on-premises or in public clouds from the mainstream hyperscalers – in fact, Chef is used by many hyperscalers themselves. same.

:like Puppet, Chef can be run standalone or in a client-server model, where a single instance of Chef can create installations on multiple machine instances (clients). The Chef server can query its clients about their capabilities and configurations, and tailor its responses accordingly, making it well suited for replicating identical builds across multi and hybrid clouds. Scalable and relatively simple data consolidations 3rd the party integration has also earned Chef a large following.

Kubernetes

Kubernetes provides automation and functions for containers, in particular. It uses several components, including a container database, container groups functioning as pods, self-replication, load balancing, and self-healing. If you’re running container-based applications in production, you’re probably using (or will be) using Kubernetes.

Kubernetes has fans in the DevOps community as microservices become mainstream. Its layered structure makes sense for developers looking to automate their containerized infrastructure as code. Although its syntax and methodology are considered opaque to all but Kubernetes experts, it proves to be an enabler of scalable, elastic, and reliable containerized applications.

Why you should deploy infrastructure as code

Infrastructure as code is a way to provide faster, more robust, and more visibly version-controlled environmental deployments in a secure manner. Process automation is an important part of operations in a development environment and can save you more money, speed up your development chain, and make it easier to manage and modify your infrastructure environments.

]]>
Additional agents for maintenance therapy of AML https://tromsosjakklubb.com/additional-agents-for-maintenance-therapy-of-aml/ Mon, 11 Jul 2022 17:06:21 +0000 https://tromsosjakklubb.com/additional-agents-for-maintenance-therapy-of-aml/ Ryan Haumschild, Doctor of Pharmacy, MS, MBA: Speaking of these more innovative agents coming in, [or have been coming] to market, Dr. McCoy, do you have any more to add? I know we’ve heard a glimpse of these agents, but [would you like] talk more in depth about anything? Cole McCoy, Doctor of Pharmacy: Dr. […]]]>

Ryan Haumschild, Doctor of Pharmacy, MS, MBA: Speaking of these more innovative agents coming in, [or have been coming] to market, Dr. McCoy, do you have any more to add? I know we’ve heard a glimpse of these agents, but [would you like] talk more in depth about anything?

Cole McCoy, Doctor of Pharmacy: Dr. McCloskey did an excellent job explaining the specific agents, as well as the purpose of maintenance therapy. From now on, in the NCCN [National Comprehensive Cancer Network] guidelines, the only type of agent is sorafenib for patients with an FLT3 mutation. We used to use sorafenib in the initial setting, but [that has] have been replaced by newer and more targeted FLT3 inhibitors. However, it is still within the guidelines for maintenance patients. A study [that Dr. McCloskey] talked a little with this flip is post-transplant. We have a study in our institution [that is] reviewing gilteritinib in maintenance. They receive gilteritinib versus a placebo. We have several patients in this study right now. The other agent who [Dr. McCloskey] currently being discussed in the NCCN is oral azacytidine, [but he’s] talk about different immunotherapies as well. This is an evolving area of ​​practice in the LMA [acute myeloid leukemia].

Ryan Haumschild, Doctor of Pharmacy, MS, MBA: It never hurts to inject other treatment options, especially those that can be tolerated. We talk about maintenance treatment, but what about patients in remission for whom there is no transplant plan? [Is there] what else do you think is going to be innovative there? What type of treatment do you typically use in this space?

Cole McCoy, Doctor of Pharmacy: I have not worked in a facility that is a large transplant center. We have a lot of transplant patients, so we’re pushing in that area. There are patients who are not good candidates for a transplant, or who simply do not want to go for a transplant. I saw [oral azacytidine used] a few times, but we don’t have too many patients because it’s a niche population.

Ryan Haumschild, Doctor of Pharmacy, MS, MBA: We talked about pre-education of patients, and when we talk about maintenance therapy, we have to prepare patients. This is important so that they understand very early on what travel is. When they get to the point where they are done with the transplant or are no longer eligible for the transplant, they [can] understand the next steps in therapy. Danielle, you treat a lot of patients and you have to educate them, provide them with expectations. How do you approach the discussion of maintenance therapy with your patients?

Danielle Marcotulli, APN, RN, MSN, FNP-BC, AOCNP: A few people have already mentioned this, but it’s important to have this conversation early. Patients often underwent induction and multiple consolidations. They have been away from their families. They were in the hospital. When you start talking to them about maintenance therapy, their immediate response is, “No. I did my chemotherapy. I want to live my life. It is important to tell them that they can maintain their quality of life. It is soft; it is well tolerated. You can go on vacation. You can do whatever you want to do, and it will help you in the long run. This conversation needs to happen when they get their intensive consolidation so they are ready to move forward.

This transcript has been edited for clarity.

]]>